GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » EV-to-Revenue

Veritas In Silico (TSE:130A) EV-to-Revenue : 11.62 (As of Jun. 02, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Veritas In Silico's enterprise value is 円2,289.8 Mil. Veritas In Silico's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was 円197.1 Mil. Therefore, Veritas In Silico's EV-to-Revenue for today is 11.62.

The historical rank and industry rank for Veritas In Silico's EV-to-Revenue or its related term are showing as below:

TSE:130A' s EV-to-Revenue Range Over the Past 10 Years
Min: 10.18   Med: 19.23   Max: 214.36
Current: 11.62

During the past 4 years, the highest EV-to-Revenue of Veritas In Silico was 214.36. The lowest was 10.18. And the median was 19.23.

TSE:130A's EV-to-Revenue is ranked worse than
59.38% of 997 companies
in the Biotechnology industry
Industry Median: 7.4 vs TSE:130A: 11.62

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-02), Veritas In Silico's stock price is 円688.00. Veritas In Silico's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was 円31.14. Therefore, Veritas In Silico's PS Ratio for today is 22.10.


Veritas In Silico EV-to-Revenue Historical Data

The historical data trend for Veritas In Silico's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico EV-to-Revenue Chart

Veritas In Silico Annual Data
Trend Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
- - - 18.23

Veritas In Silico Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24 Dec24
EV-to-Revenue Get a 7-Day Free Trial - - 94.42 24.69 18.23

Competitive Comparison of Veritas In Silico's EV-to-Revenue

For the Biotechnology subindustry, Veritas In Silico's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veritas In Silico's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Veritas In Silico's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Veritas In Silico's EV-to-Revenue falls into.


;
;

Veritas In Silico EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Veritas In Silico's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2289.776/197.103
=11.62

Veritas In Silico's current Enterprise Value is 円2,289.8 Mil.
Veritas In Silico's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円197.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Veritas In Silico  (TSE:130A) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Veritas In Silico's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=688.00/31.136
=22.10

Veritas In Silico's share price for today is 円688.00.
Veritas In Silico's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円31.14.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Veritas In Silico EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Veritas In Silico Business Description

Traded in Other Exchanges
N/A
Address
1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines